Litigation Details for Allergan USA, Inc. v. Sun Pharmaceutical Industries Limited (D. Del. 2019)
✉ Email this page to a colleague
Allergan USA, Inc. v. Sun Pharmaceutical Industries Limited (D. Del. 2019)
| Docket | ⤷ Try a Trial | Date Filed | 2019-12-20 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Parties | ALLERGAN SALES, LLC; ALLERGAN USA, INC.; AUROBINDO PHARMA LIMITED; AUROBINDO PHARMA USA, INC.; CADILA HEALTHCARE LIMITED; FOREST LABORATORIES HOLDINGS LIMITED; GEDEON RICHTER PLC.; SUN PHARMA GLOBAL FZE; SUN PHARMACEUTICAL INDUSTRIES LIMITED; ZYDUS PHARMACEUTICALS (USA), INC. | ||
| Patents | RE47,128 | ||
| Attorneys | Jack B. Blumenfeld; Jeremy A. Tigan; Kelly E. Farnan; Kenneth Laurence Dorsney; Matthew M. Holub | ||
| Firms | Morris James LLP; Morris, Nichols, Arsht & Tunnell | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in Allergan USA, Inc. v. Sun Pharmaceutical Industries Limited
The biologic drug covered by the patent cited in this case is ⤷ Try a Trial .
Details for Allergan USA, Inc. v. Sun Pharmaceutical Industries Limited (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-12-20 | 1 | Complaint | has listed the asserted patents and U.S. Patent No. RE47,350 (“the ’350 Patent”) in the Approved Drug …’142 Patent. 128. Zydus did not contest infringement of any claims of the ’142 Patent in Zydus…United States Patent Nos. 7,737,142 (“the ’142 Patent”) and 7,943,621 (“the ’621 Patent”) (collectively… 1. This action for patent infringement, brought pursuant to the patent laws of the United States…28. This civil action for patent infringement arises under the patent laws of the United States, including | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
